Spark Therapeutics competitors

Spark Therapeutics Competitors include Guardant Health, ImaginAb, Orgenesis and Nohla Therapeutics.
Add company...
Spark Therapeutics
Spark Therapeutics
Spark Therapeutics is a gene therapy company.
Guardant Health
Guardant Health
Guardant Health is committed to positively and significantly impacting patient health through technology breakthroughs in oncology.
ImaginAb
ImaginAb
ImaginAb clinically manages cancer and autoimmune diseases via molecular imaging by re-engineering antibodies into small proteins.
Orgenesis
Orgenesis
Orgenesis focuses on a novel therapeutic treatment for diabetes by correcting malfunctioning organs with new functional tissues.
Nohla Therapeutics
Nohla Therapeutics
Nohla is a cellular therapy company driven by a powerful vision to provide off-the-shelf treatment for critical care patients around the world.
Founding Date
Founding Date
2013
Founding Date
2012
Founding Date
2007
Founding Date
2008
Founding Date
2015
Type
Type
Public
Type
Public
Type
Private
Type
Private
Type
Private
Tags
Locations
Locations
Philadelphia, US HQ
Locations
Redwood City, US HQ
The Woodlands, US
Locations
Inglewood, US HQ
Locations
White Plains, US HQ
Locations
Seattle, US HQ
South Melbourne, AU
Melbourne, AU
Seattle, US
Employees
Employees
213
Employees
3486% decrease
Employees
26
Employees
80
Employees
476% decrease
Twitter followers
Twitter followers
1.7 k
Twitter followers
1.7 k
Twitter followers
N/A
Twitter followers
N/A
Twitter followers
115

Financial

Revenue (est.)
Revenue (est.)
$64.7m (FY, 2018)
Revenue (est.)
$49.8m (FY, 2017)
Revenue (est.)
N/A
Revenue (est.)
$18.7m (FY, 2018)
Revenue (est.)
N/A
Cost of goods
Cost of goods
$1m (FY, 2018)
Cost of goods
$31.6m (FY, 2017)
Cost of goods
N/A
Cost of goods
$10.8m (FY, 2018)
Cost of goods
N/A
Gross profit
Gross profit
$63.7m (FY, 2018)
Gross profit
$18.2m (FY, 2017)
Gross profit
N/A
Gross profit
$7.8m (FY, 2018)
Gross profit
N/A
Net income
Net income
($78.8m) (FY, 2018)
Net income
($83.2m) (FY, 2017)
Net income
N/A
Net income
$19.1m (FY, 2018)
Net income
N/A

Funding

Latest funding round
Latest funding round
N/A
Latest funding round
N/A
Latest funding round
$ 8m (over 1 year ago)
Latest funding round
N/A
Latest funding round
$ 43.5m (over 2 years ago)
Total funding raised
Total funding raised
$ 122.8m
Total funding raised
$ 550m
Total funding raised
$ 46.8m
Total funding raised
N/A
Total funding raised
$ 64.5m
For sources of this data, please see the company profileDownload Excel

View company profiles

Guardant Health
HQ
Redwood City, US
Employees
348↓ 6% decrease

Guardant Health is committed to positively and significantly impacting patient health through technology breakthroughs in oncology.

View company
ImaginAb
HQ
Inglewood, US
Employees
26

ImaginAb clinically manages cancer and autoimmune diseases via molecular imaging by re-engineering antibodies into small proteins.

View company
Orgenesis
HQ
White Plains, US
Employees
80

Orgenesis focuses on a novel therapeutic treatment for diabetes by correcting malfunctioning organs with new functional tissues.

View company
Nohla Therapeutics
HQ
Seattle, US
Employees
47↓ 6% decrease

Nohla is a cellular therapy company driven by a powerful vision to provide off-the-shelf treatment for critical care patients around the world.

View company